question stringclasses 185
values | answer stringclasses 37
values | reasoning stringlengths 1.64k 3.03k | reference_sequence stringlengths 4k 4.07k | variant_sequence stringlengths 4k 4.26k |
|---|---|---|---|---|
Chromosome Number: 4
Network Definition of the pathway: (PDE11A*,PDE8B*) // cAMP -> (PRKAR1A+PRKACA) -> (NR5A1,NR4A1,SP1,PBX1,CREB) => (STAR,CYP11B1) -> Cortisol
Genes in the pathway: PDE11A; phosphodiesterase 11A | PDE8B; phosphodiesterase 8B | PRKAR1A; protein kinase cAMP-dependent type I regulatory subunit alpha | P... | cushing syndrome | Step 1: The C>T variant in PDE11A likely results in a missense or nonsense mutation that alters the protein structure or creates a premature stop codon.
Step 2: PDE11A encodes phosphodiesterase 11A, an enzyme responsible for hydrolyzing cyclic adenosine monophosphate (cAMP) to its inactive form 5'-AMP.
Step 3: Loss of ... | ACTTTATGCTTCCCTACTGCCCTAATTTAGGCCCTGTCATCTCTCACCTGGACAGCCTCCTCACTTAGCTCTCTGTCATCACTCTCTCTACAGTTTCTGCTGCCAGTTTTATTTTTCTAACAGAAAGATCTGATTATACCTCACCTCTTCCCCCACCTACAGCTTTGAAATCATCATGTCTTTCCATTAAACATAAGTTCAAATTCTAGGTCTACTATTATATTCCCTTCAAACTCTAGCCCACCCATCTTCCAAAATTTATTTCCTACCACATCTCTCCCTTCCCAAAATATATCATATTCTTACATCCTTCAGAGCTT... | ACTTTATGCTTCCCTACTGCCCTAATTTAGGCCCTGTCATCTCTCACCTGGACAGCCTCCTCACTTAGCTCTCTGTCATCACTCTCTCTACAGTTTCTGCTGCCAGTTTTATTTTTCTAACAGAAAGATCTGATTATACCTCACCTCTTCCCCCACCTACAGCTTTGAAATCATCATGTCTTTCCATTAAACATAAGTTCAAATTCTAGGTCTACTATTATATTCCCTTCAAACTCTAGCCCACCCATCTTCCAAAATTTATTTCCTACCACATCTCTCCCTTCCCAAAATATATCATATTCTTACATCCTTCAGAGCTT... |
Chromosome Number: 4
Network Definition of the pathway: SNCA* // TH -> L-Dopa
Genes in the pathway: SNCA; synuclein alpha | TH; tyrosine hydroxylase
Given this context, what is the biological effect of this SNCA allele, specifically what disease does this contribute to? | parkinson's disease | Step 1: The variant KEGG_1163 is an A>G substitution at position 89828155 on chromosome 4, which is located within the SNCA gene encoding alpha-synuclein protein.
Step 2: This nucleotide change likely results in a missense mutation, altering an amino acid in the alpha-synuclein protein sequence, potentially affecting i... | TATTGCACATGCTGAAATCACCATGTCCTTACTGCCTAGCAACATTTCCCATAGTTTTCTGTGGAACACTAGTTTCATTCAACCCTAGTAACTAATGAAGAAAGTTTTCAATAATCAAAAAGTTTGAATAACCCTGATTTTAACTATGTAATGCAAATTTCTTTACTGTAGGACATCTCAGATTCCTTAATACGCTAAAGAGAAAATAAAGTATACAAAGTCTCCCAACATTGTACAATGTTAGAAACTTAAGATTGTGAGCCACTGTCCTTCAGAAAACATTTTATAAAATGTCTAATTGTACAAACTTCAGTCTCTCT... | TATTGCACATGCTGAAATCACCATGTCCTTACTGCCTAGCAACATTTCCCATAGTTTTCTGTGGAACACTAGTTTCATTCAACCCTAGTAACTAATGAAGAAAGTTTTCAATAATCAAAAAGTTTGAATAACCCTGATTTTAACTATGTAATGCAAATTTCTTTACTGTAGGACATCTCAGATTCCTTAATACGCTAAAGAGAAAATAAAGTATACAAAGTCTCCCAACATTGTACAATGTTAGAAACTTAAGATTGTGAGCCACTGTCCTTCAGAAAACATTTTATAAAATGTCTAATTGTACAAACTTCAGTCTCTCT... |
Chromosome Number: 5
Network Definition of the pathway: PINK1 -> PRKN -> (CISD1,CISD2,FAF2,FKBP8,TOMM70,HK1) // SQSTM1* // LC3
Genes in the pathway: PINK1; PTEN induced kinase 1 | PRKN; parkin RBR E3 ubiquitin protein ligase | CISD1; CDGSH iron sulfur domain 1 | CISD2; CDGSH iron sulfur domain 2 | FAF2; Fas associated ... | amyotrophic lateral sclerosis | Step 1: The variant KEGG_1426 is a T to TT change (duplication) at position 179836493 on chromosome 5, occurring in the SQSTM1 gene which encodes the p62/sequestosome 1 protein.
Step 2: This duplication causes a frameshift mutation, likely resulting in a premature stop codon and truncated p62 protein or nonsense-mediat... | GAGGGAAGGTCAGCAGATAAACAAGTGAACAAAGGTCTCTGGTTTTCCTAGGCAGAGGACCCTGCGGCCTTCCGCAGCGTTTGTGTCCCTGGGTACTTGAGATTAGGGAGTGGTGATGACTCTTAAGGAGCATGCTGCCTTCAAGCATCTGTTTAACAAAGCACATCTTGCACCGCCCTTAATCCATTTAACCCTGAGTGGACACAGCACATGTTTCAGAGAGCACGGGGTTGGGGGTAAGGTCACAGATCAACAGGATAAGAATTTTTCTTAGTACAGAACAAAATGAAAAGTCTCCCATGTCTACTTCTTTCCACACA... | GAGGGAAGGTCAGCAGATAAACAAGTGAACAAAGGTCTCTGGTTTTCCTAGGCAGAGGACCCTGCGGCCTTCCGCAGCGTTTGTGTCCCTGGGTACTTGAGATTAGGGAGTGGTGATGACTCTTAAGGAGCATGCTGCCTTCAAGCATCTGTTTAACAAAGCACATCTTGCACCGCCCTTAATCCATTTAACCCTGAGTGGACACAGCACATGTTTCAGAGAGCACGGGGTTGGGGGTAAGGTCACAGATCAACAGGATAAGAATTTTTCTTAGTACAGAACAAAATGAAAAGTCTCCCATGTCTACTTCTTTCCACACA... |
Chromosome Number: 1
Network Definition of the pathway: TARDBP* -| CxI -> Q
Genes in the pathway: TARDBP; TAR DNA binding protein | ND1; NADH dehydrogenase, subunit 1 (complex I) | ND2; MTND2 | ND3; NADH dehydrogenase, subunit 3 (complex I) | ND4; NADH dehydrogenase, subunit 4 (complex I) | ND5; NADH dehydrogenase, sub... | amyotrophic lateral sclerosis | Step 1: The variant KEGG_189 is a G>A substitution at position 11022300 on chromosome 1, occurring in the TARDBP gene which encodes the TAR DNA-binding protein (TDP-43).
Step 2: This mutation likely results in a missense variant that alters the amino acid sequence of TDP-43, potentially affecting its structure and func... | GGTACGTCTACTTTTTAATGGTTCACTGCTATCCAAGGCGAATGATTTTGTTATATCCCTTACCTTAATGTTTTTTTCATTGTTCATAACATATTTCTGAGTTTTTTTCTTCCTTTTGATTTGATCAGCAAAGCCAAGATGAGCCTTTGAGAAGCAGAAAAGTGTTTGTGGGGCGCTGTACAGAGGACATGACTGAGGATGAGCTGCGGGAGTTCTTCTCTCAGTACGGGGATGTGATGGATGTCTTCATCCCCAAGCCATTCAGGGCCTTTGCCTTTGTTACATTTGCAGATGATCAGGTATTTTTCTCCTTAACGATA... | GGTACGTCTACTTTTTAATGGTTCACTGCTATCCAAGGCGAATGATTTTGTTATATCCCTTACCTTAATGTTTTTTTCATTGTTCATAACATATTTCTGAGTTTTTTTCTTCCTTTTGATTTGATCAGCAAAGCCAAGATGAGCCTTTGAGAAGCAGAAAAGTGTTTGTGGGGCGCTGTACAGAGGACATGACTGAGGATGAGCTGCGGGAGTTCTTCTCTCAGTACGGGGATGTGATGGATGTCTTCATCCCCAAGCCATTCAGGGCCTTTGCCTTTGTTACATTTGCAGATGATCAGGTATTTTTCTCCTTAACGATA... |
Chromosome Number: 20
Network Definition of the pathway: GNAS* -> ADCY -> cAMP -> PKA -> CREB -> ACTH
Genes in the pathway: GNAS; GNAS complex locus | ADCY1; adenylate cyclase 1 | ADCY2; adenylate cyclase 2 | ADCY3; adenylate cyclase 3 | ADCY4; adenylate cyclase 4 | ADCY5; adenylate cyclase 5 | ADCY6; adenylate cyclase... | cushing syndrome | Step 1: The variant KEGG_272 is an A>C substitution at position 58909540 on chromosome 20, which is located in the GNAS gene that encodes the alpha subunit of the stimulatory G protein (Gsα).
Step 2: GNAS mutations can affect the GTPase activity of the Gsα protein, potentially leading to a constitutively active protein... | AGGGAGACCCAGTTTCGTTAATTAACAGTAGCTTAGCCAGATTGTTGAATTTTGTCGGGTTTCGTTTTCTCTCTCAAATCATTTAGAAGTTTTTGGGGTTTTTTTAAGCAACACTTAATTACTCCTGAAACTTTGTCTGAAAACGCACCATTTGTATAGATCATGAAAAGTTTTAAGGAAACTCAGAGAAAAAGAGAACAACGCAGCTTAAAACTTTTAAAATGTCCTCCCTCACCCGTGGCTCAAACAGCCCTGCATCTGCCGTGGCCGGCACGTTTCTGGTTGAACTGCCTTTATGTTAAAGTTCAGATACTGGTAGT... | AGGGAGACCCAGTTTCGTTAATTAACAGTAGCTTAGCCAGATTGTTGAATTTTGTCGGGTTTCGTTTTCTCTCTCAAATCATTTAGAAGTTTTTGGGGTTTTTTTAAGCAACACTTAATTACTCCTGAAACTTTGTCTGAAAACGCACCATTTGTATAGATCATGAAAAGTTTTAAGGAAACTCAGAGAAAAAGAGAACAACGCAGCTTAAAACTTTTAAAATGTCCTCCCTCACCCGTGGCTCAAACAGCCCTGCATCTGCCGTGGCCGGCACGTTTCTGGTTGAACTGCCTTTATGTTAAAGTTCAGATACTGGTAGT... |
Chromosome Number: 1
Network Definition of the pathway: PINK1* // (HTRA2,TRAP1) // CYCS == APAF1 -> CASP9 -> CASP3
Genes in the pathway: PINK1; PTEN induced kinase 1 | HTRA2; HtrA serine peptidase 2 | TRAP1; TNF receptor associated protein 1 | CYCS; cytochrome c, somatic | APAF1; apoptotic peptidase activating factor 1... | parkinson's disease | Step 1: The variant is a duplication (AGTTAG>AGTTAGTTAG) in the PINK1 gene, which encodes PTEN-induced kinase 1, a mitochondrial serine/threonine-protein kinase.
Step 2: This duplication likely results in the insertion of two amino acids (serine and leucine) in the protein sequence, potentially disrupting the protein's... | CCCTGGCTGGTGATCGCAGATTTTGGCTGCTGCCTGGCTGATGAGAGCATCGGCCTGCAGTTGCCCTTCAGCAGCTGGTACGTGGATCGGGGCGGAAACGGCTGTCTGATGGCCCCAGAGGTGAGTCCCGAGTGTGTCATGCGCCATCGGCAGCCCTTCCCCCACATGTCCACTGAATGCAGGAGACTCGATGCCTTGTGATAACCCAACACCTCCATCTTTTCTGACCCATAATTTGGCACAAGTTCCTTCCCTGCCACTTTGCTTTCCTCCGGCGTTCCCTCATGTTCCAGGAGAATGCAAGTCCTGTCACATAAACC... | CCCTGGCTGGTGATCGCAGATTTTGGCTGCTGCCTGGCTGATGAGAGCATCGGCCTGCAGTTGCCCTTCAGCAGCTGGTACGTGGATCGGGGCGGAAACGGCTGTCTGATGGCCCCAGAGGTGAGTCCCGAGTGTGTCATGCGCCATCGGCAGCCCTTCCCCCACATGTCCACTGAATGCAGGAGACTCGATGCCTTGTGATAACCCAACACCTCCATCTTTTCTGACCCATAATTTGGCACAAGTTCCTTCCCTGCCACTTTGCTTTCCTCCGGCGTTCCCTCATGTTCCAGGAGAATGCAAGTCCTGTCACATAAACC... |
Chromosome Number: 19
Network Definition of the pathway: Ca2+(extracellular) -- CACNA1A* -> Ca2+
Genes in the pathway: CACNA1A; calcium voltage-gated channel subunit alpha1 A
Given this context, what is the biological effect of this CACNA1A allele, specifically what disease does this contribute to? | spinocerebellar ataxia | Step 1: The variant is an A>T substitution at position 13257473 on chromosome 19, occurring in the CACNA1A gene.
Step 2: CACNA1A encodes the alpha-1A subunit of the P/Q-type voltage-gated calcium channel, which is highly expressed in cerebellar neurons.
Step 3: This channel regulates calcium influx into neurons, contro... | AAAACTTGCACTGACATTTCCCCATTATTGCATGGCTAATACAAACATGGGAAGTGGGTACTATCAATGGCCTCACTTTGCAGATCACCAAAATAGAGGCTTAGAAAGGTTAAACCACTTGCCTGAGGTGACACAGCTACCGAGTGTGCCAAATCAAATTGAAGCCTAATCCTTCTTCCCCTTCCTCCCTCCCTCGCTCCCTCCCTCCTTCCTTCCTTCCTCCCTCCTTCCTTCCCTCCCTCCCTCCTTCTCTCCCTCCCTCCTTCCCTCCCTCCCTCCTTCCCTCCCTCCTTCCCTCCCTCCTTTCCTTCCTTCCTCCC... | AAAACTTGCACTGACATTTCCCCATTATTGCATGGCTAATACAAACATGGGAAGTGGGTACTATCAATGGCCTCACTTTGCAGATCACCAAAATAGAGGCTTAGAAAGGTTAAACCACTTGCCTGAGGTGACACAGCTACCGAGTGTGCCAAATCAAATTGAAGCCTAATCCTTCTTCCCCTTCCTCCCTCCCTCGCTCCCTCCCTCCTTCCTTCCTTCCTCCCTCCTTCCTTCCCTCCCTCCCTCCTTCTCTCCCTCCCTCCTTCCCTCCCTCCCTCCTTCCCTCCCTCCTTCCCTCCCTCCTTTCCTTCCTTCCTCCC... |
Chromosome Number: 20
Network Definition of the pathway: PRNP* -| VGCC(N,L-type) -> Ca2+
Genes in the pathway: PRNP; prion protein | CACNA1B; calcium voltage-gated channel subunit alpha1 B | CACNA1C; calcium voltage-gated channel subunit alpha1 C | CACNA1D; calcium voltage-gated channel subunit alpha1 D | CACNA1F; calc... | creutzfeldt-jakob disease | Step 1: The T>C mutation at position 4699812 on chromosome 20 occurs in the PRNP gene, which encodes the prion protein (PrP).
Step 2: This mutation likely alters the amino acid sequence of the prion protein, affecting its three-dimensional structure and stability.
Step 3: The structural change promotes misfolding of th... | TGATGGAAGCACCGAATAAGATGGTCATGTTGGAAAAATTGAGAAGCTGAGGTGCTTAGCATTGATTTTCAAGGTAGAGCTACTGAGATTTGCTGATAGATCCAATGTATGCTGGGAGAGAAAATTCAGTCACTCTAGAGCATTGGCTGGATTTGTCACCCATTGCAGCGAATGGAGAAGGTGCTGACATAAAAGCCCTTTAGACTGAAAGCTACTGACTGAGGGGATGGTGCCCTAGTTTGATTTCCTGGGGTGTATGAGTAGCAGGGAGGCCAAGAGCTGGGCCTCACGAGATTGTGGGGACTACATCAGGGAAGCAG... | TGATGGAAGCACCGAATAAGATGGTCATGTTGGAAAAATTGAGAAGCTGAGGTGCTTAGCATTGATTTTCAAGGTAGAGCTACTGAGATTTGCTGATAGATCCAATGTATGCTGGGAGAGAAAATTCAGTCACTCTAGAGCATTGGCTGGATTTGTCACCCATTGCAGCGAATGGAGAAGGTGCTGACATAAAAGCCCTTTAGACTGAAAGCTACTGACTGAGGGGATGGTGCCCTAGTTTGATTTCCTGGGGTGTATGAGTAGCAGGGAGGCCAAGAGCTGGGCCTCACGAGATTGTGGGGACTACATCAGGGAAGCAG... |
Chromosome Number: 6
Network Definition of the pathway: PRKN* // BAX -> CYCS == APAF1 -> CASP9 -> CASP3
Genes in the pathway: PRKN; parkin RBR E3 ubiquitin protein ligase | BAX; BCL2 associated X, apoptosis regulator | CYCS; cytochrome c, somatic | APAF1; apoptotic peptidase activating factor 1 | CASP9; caspase 9 | CAS... | parkinson's disease | Step 1: The G>T substitution at position 161785819 on chromosome 6 occurs in the PRKN gene, which encodes Parkin, an E3 ubiquitin ligase.
Step 2: This mutation likely alters a critical amino acid in the Parkin protein, disrupting its three-dimensional structure and compromising its E3 ubiquitin ligase activity.
Step 3:... | TAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGT... | TAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGT... |
Chromosome Number: 14
Network Definition of the pathway: PSEN1* -| ERN1 -> XBP1
Genes in the pathway: PSEN1; presenilin 1 | ERN1; endoplasmic reticulum to nucleus signaling 1 | XBP1; X-box binding protein 1
Given this context, what is the biological effect of this PSEN1 allele, specifically what disease does this cont... | alzheimer's disease | Step 1: The variant KEGG_995 represents a G>C substitution at position 73198093 on chromosome 14, occurring within the PSEN1 gene that encodes presenilin 1 protein.
Step 2: Presenilin 1 is a catalytic subunit of the gamma-secretase complex, which cleaves amyloid precursor protein (APP) and is critical for proper APP pr... | ATTCTCGGCTCCATTTTTACAAGATTTCAAGATTTAATTTGTCAAAAAAGTTCTGAAATTTTCAAAGCAAAAGCAATTTTAATTTAATTGCTCTAAAAAATAAGCAGATTTATCATTTAGCAATTCTTTAAGGGAGAGTGTATCATAAAACTGAAATAGTACTGAATGTGGCAGAATCAAACAAGTTGAAAATCTCATCACTTCAGAGCAGGGCAGACTTCTCATTCAAACAAATTGAGGTAGAAGTGGTGAGAGTAGAGATTTCTTTGTGTATGTGTGTTTTATTACTGTACTATATTATATTATAGTTCTATATATAC... | ATTCTCGGCTCCATTTTTACAAGATTTCAAGATTTAATTTGTCAAAAAAGTTCTGAAATTTTCAAAGCAAAAGCAATTTTAATTTAATTGCTCTAAAAAATAAGCAGATTTATCATTTAGCAATTCTTTAAGGGAGAGTGTATCATAAAACTGAAATAGTACTGAATGTGGCAGAATCAAACAAGTTGAAAATCTCATCACTTCAGAGCAGGGCAGACTTCTCATTCAAACAAATTGAGGTAGAAGTGGTGAGAGTAGAGATTTCTTTGTGTATGTGTGTTTTATTACTGTACTATATTATATTATAGTTCTATATATAC... |
Chromosome Number: 4
Network Definition of the pathway: SNCA* -| CxI -> Q
Genes in the pathway: SNCA; synuclein alpha | ND1; NADH dehydrogenase, subunit 1 (complex I) | ND2; MTND2 | ND3; NADH dehydrogenase, subunit 3 (complex I) | ND4; NADH dehydrogenase, subunit 4 (complex I) | ND5; NADH dehydrogenase, subunit 5 (comp... | parkinson's disease | Step 1: The variant KEGG_1166 is an A>C substitution at position 89828155 on chromosome 4, occurring in the SNCA gene which encodes alpha-synuclein protein.
Step 2: This mutation likely results in a missense variant that changes an amino acid in the alpha-synuclein protein, potentially affecting its structure and funct... | TATTGCACATGCTGAAATCACCATGTCCTTACTGCCTAGCAACATTTCCCATAGTTTTCTGTGGAACACTAGTTTCATTCAACCCTAGTAACTAATGAAGAAAGTTTTCAATAATCAAAAAGTTTGAATAACCCTGATTTTAACTATGTAATGCAAATTTCTTTACTGTAGGACATCTCAGATTCCTTAATACGCTAAAGAGAAAATAAAGTATACAAAGTCTCCCAACATTGTACAATGTTAGAAACTTAAGATTGTGAGCCACTGTCCTTCAGAAAACATTTTATAAAATGTCTAATTGTACAAACTTCAGTCTCTCT... | TATTGCACATGCTGAAATCACCATGTCCTTACTGCCTAGCAACATTTCCCATAGTTTTCTGTGGAACACTAGTTTCATTCAACCCTAGTAACTAATGAAGAAAGTTTTCAATAATCAAAAAGTTTGAATAACCCTGATTTTAACTATGTAATGCAAATTTCTTTACTGTAGGACATCTCAGATTCCTTAATACGCTAAAGAGAAAATAAAGTATACAAAGTCTCCCAACATTGTACAATGTTAGAAACTTAAGATTGTGAGCCACTGTCCTTCAGAAAACATTTTATAAAATGTCTAATTGTACAAACTTCAGTCTCTCT... |
Chromosome Number: 21
Network Definition of the pathway: APP* -> Abeta -| 26S
Genes in the pathway: APP; amyloid beta precursor protein | PSMA6; proteasome 20S subunit alpha 6 | PSMA2; proteasome 20S subunit alpha 2 | PSMA4; proteasome 20S subunit alpha 4 | PSMA7; proteasome 20S subunit alpha 7 | PSMA8; proteasome 20S ... | alzheimer's disease | Step 1: The C>G mutation at position 25891783 on chromosome 21 occurs in the APP gene, which encodes the amyloid precursor protein.
Step 2: This mutation likely alters the proteolytic processing of APP, potentially affecting the cleavage sites for β-secretase (BACE1) and γ-secretase.
Step 3: Altered APP processing lead... | TTGCAGTGAGCGGAGATCATGCCACTGCACTCCAGCCTGGGTGAAAGAGCAAGACTCCATCTCAAAAAACAAAGAAACAACAACAACAAAAGAAAACAACAAAACCATGAAAAAAACCAAAACAACAACAGCAGCAAAAAAGGGGTCTTGAATTACTCAAGTATGAAGACATCTTTATTTGCTCAAATATGGAATTAAATTTTTTTAAAAATTAATTTGAGCAGAAATGAAATAAGCTGATACTAATGAAAACCTATCTTACACTGTTTTGAGGGACATAAGCTTAGATACTATCACAAAAGGTGCAATGGCCAAACATG... | TTGCAGTGAGCGGAGATCATGCCACTGCACTCCAGCCTGGGTGAAAGAGCAAGACTCCATCTCAAAAAACAAAGAAACAACAACAACAAAAGAAAACAACAAAACCATGAAAAAAACCAAAACAACAACAGCAGCAAAAAAGGGGTCTTGAATTACTCAAGTATGAAGACATCTTTATTTGCTCAAATATGGAATTAAATTTTTTTAAAAATTAATTTGAGCAGAAATGAAATAAGCTGATACTAATGAAAACCTATCTTACACTGTTTTGAGGGACATAAGCTTAGATACTATCACAAAAGGTGCAATGGCCAAACATG... |
Chromosome Number: 1
Network Definition of the pathway: DJ1* // (DAXX+ASK1) -> JNK
Genes in the pathway: PARK7; Parkinsonism associated deglycase | DAXX; death domain associated protein | MAP3K5; mitogen-activated protein kinase kinase kinase 5 | MAPK8; mitogen-activated protein kinase 8 | MAPK9; mitogen-activated prot... | parkinson's disease | Step 1: The T>C variant at position 7984980 on chromosome 1 occurs in the PARK7 gene, which encodes the DJ-1 protein (Parkinsonism associated deglycase).
Step 2: DJ-1 normally functions as a multifunctional protein with roles in oxidative stress response, acting as a peroxiredoxin-like peroxidase that scavenges hydroge... | GCAGTGGCTTGGTTTCTAATGACAGTAAGACAAGTTCCTATAGCCATTGTTAATCTCCTTGGAAAAGAAATGAACACTGTGTGGTTTCAGAAGCTCATTAATATAGCAGAAGCACTCTGCTTCTGTTTGAAGGGAGGTTTTCAGATGAATTTTTCTGCGTGTTCATTGAACAGACGTTTCCTAAGCTCCTCCTTAGTGCCTGGCACTGGGAACAGAAGAAGGAAGAAGAGAAAGCTGTGCCCTCAGGGTGTTCTCAGGTCCGCACTGAGCGGTGGTGACCAGAGCCACCCGCCTGCCTGCGTGGCCGGTGCATCAGGATA... | GCAGTGGCTTGGTTTCTAATGACAGTAAGACAAGTTCCTATAGCCATTGTTAATCTCCTTGGAAAAGAAATGAACACTGTGTGGTTTCAGAAGCTCATTAATATAGCAGAAGCACTCTGCTTCTGTTTGAAGGGAGGTTTTCAGATGAATTTTTCTGCGTGTTCATTGAACAGACGTTTCCTAAGCTCCTCCTTAGTGCCTGGCACTGGGAACAGAAGAAGGAAGAAGAGAAAGCTGTGCCCTCAGGGTGTTCTCAGGTCCGCACTGAGCGGTGGTGACCAGAGCCACCCGCCTGCCTGCGTGGCCGGTGCATCAGGATA... |
Chromosome Number: 1
Network Definition of the pathway: DJ1* // BCL2L1 // BAX
Genes in the pathway: PARK7; Parkinsonism associated deglycase | BCL2L1; BCL2 like 1 | BAX; BCL2 associated X, apoptosis regulator
Given this context, what is the biological effect of this PARK7 allele, specifically what disease does this co... | parkinson's disease | Step 1: The G>A substitution at position 7962862 on chromosome 1 occurs in the PARK7 gene (also known as DJ-1), likely resulting in a cysteine to tyrosine amino acid change at position 106 (C106Y) in the DJ-1 protein.
Step 2: Cysteine 106 is a highly conserved residue in the DJ-1 protein and functions as a critical oxi... | TAGCGTTGGCAGAGTTCTGTAGGGTGACTATAGTTAACAGTAATCTGTTGTATATTTTAAAATGTTATTATTGAAGAGAGTAACTGGAATGTTCCCAGTATAAAGACAAATGTTTAAGGTGATAGAGATCTCATTTACCCTGATTTAATCATTACACATTATATGAAAGTATCAAAATACCACATGTACCCAGAAAACACATACGTCTCTTACATATCAATAAATACAACTTGAGATTATGATGTAAATACATCTGACCAACTTGGTACTTATTAGACTTATGTGCGCAGCACTGCTCTAGTCCTGTGGGTGCAGCAGCA... | TAGCGTTGGCAGAGTTCTGTAGGGTGACTATAGTTAACAGTAATCTGTTGTATATTTTAAAATGTTATTATTGAAGAGAGTAACTGGAATGTTCCCAGTATAAAGACAAATGTTTAAGGTGATAGAGATCTCATTTACCCTGATTTAATCATTACACATTATATGAAAGTATCAAAATACCACATGTACCCAGAAAACACATACGTCTCTTACATATCAATAAATACAACTTGAGATTATGATGTAAATACATCTGACCAACTTGGTACTTATTAGACTTATGTGCGCAGCACTGCTCTAGTCCTGTGGGTGCAGCAGCA... |
Chromosome Number: 12
Network Definition of the pathway: KRAS* -> RALGDS -> RAL
Genes in the pathway: KRAS; KRAS proto-oncogene, GTPase | RALGDS; ral guanine nucleotide dissociation stimulator | RALA; RAS like proto-oncogene A | RALB; RAS like proto-oncogene B
Given this context, what is the biological effect of this ... | colorectal cancer | Step 1: The variant KEGG_529 is a C>G substitution at position 25245349 on chromosome 12, which is located in the KRAS gene.
Step 2: This mutation likely occurs in codon 12 of KRAS, resulting in a glycine to valine amino acid substitution (G12V), a common oncogenic mutation.
Step 3: The G12V mutation impairs the intrin... | GTCAGTTTCAAAGTTCACAGGTAACCAATGCTTCCCAGAGTCAAGTCTTCTGGTTTGGCAGAAATCATAAGCAGAGTTATAGGTTTAAGTTTATAAACTTTTTCAGCCTTCCGCCCAAATAAAGGCTTAACTGTTAGCTTTATTTCTTCAACATTTATATTGCATTTTAACAATCATTAGCAAAAGGTTTCCTAACCCACTTTATCACATTCATGACGTCATGCTGTATATACTCATATAGCACTCATGACCTCTGATTGGAAACAAAGTGTAATGGAATTTCTCAGATTTTCAGGGAAGACAGACAGCATTTCCAGTAA... | GTCAGTTTCAAAGTTCACAGGTAACCAATGCTTCCCAGAGTCAAGTCTTCTGGTTTGGCAGAAATCATAAGCAGAGTTATAGGTTTAAGTTTATAAACTTTTTCAGCCTTCCGCCCAAATAAAGGCTTAACTGTTAGCTTTATTTCTTCAACATTTATATTGCATTTTAACAATCATTAGCAAAAGGTTTCCTAACCCACTTTATCACATTCATGACGTCATGCTGTATATACTCATATAGCACTCATGACCTCTGATTGGAAACAAAGTGTAATGGAATTTCTCAGATTTTCAGGGAAGACAGACAGCATTTCCAGTAA... |
Chromosome Number: 2
Network Definition of the pathway: TG+(Iodide+Tyr) -- TPO* // TG+(MIT,DIT) -- TPO* // TG+(T3,T4)
Genes in the pathway: TG; thyroglobulin | TPO; thyroid peroxidase
Given this context, what is the biological effect of this TPO allele, specifically what disease does this contribute to? | thyroid dyshormonogenesis | Step 1: The variant KEGG_1326 is a duplication of a cytosine (C) nucleotide in the TPO gene, resulting in an insertion of an additional C in a string of seven C nucleotides.
Step 2: This insertion causes a frameshift mutation, altering the reading frame of the TPO gene downstream of position 1503975.
Step 3: The frames... | GGGCAGAAGCTGCTCCAAGGGAACTCCCCGAGAGGGATGCAGGGATGTGTTGGCAGCTGCCATTCCCATTCTGAGGACCCCATTGCACATCCCAGGGGATGGAGAGAAAATGGGCTTGTAGCGTTCATGGGTGATGACTTTGATTTTTCACACGATCATGATGGAAACACTCCCTACCCCAGAGGCGGCTGCAGATGCCTTCACACAGCTCTGGTGCTCCACAGCTCTGCATAACGGGATGCAGGAGGGGCTGGTTCCAGGGGCAGCTTTAGCCAAGAAAGACCTTCTAGGTTTAACAGCCTTGACATGGTTACCTGTAC... | GGGCAGAAGCTGCTCCAAGGGAACTCCCCGAGAGGGATGCAGGGATGTGTTGGCAGCTGCCATTCCCATTCTGAGGACCCCATTGCACATCCCAGGGGATGGAGAGAAAATGGGCTTGTAGCGTTCATGGGTGATGACTTTGATTTTTCACACGATCATGATGGAAACACTCCCTACCCCAGAGGCGGCTGCAGATGCCTTCACACAGCTCTGGTGCTCCACAGCTCTGCATAACGGGATGCAGGAGGGGCTGGTTCCAGGGGCAGCTTTAGCCAAGAAAGACCTTCTAGGTTTAACAGCCTTGACATGGTTACCTGTAC... |
Chromosome Number: 9
Network Definition of the pathway: CDKN2A* // (CCND+CDK4/6) -> RB1 // E2F
Genes in the pathway: CDKN2A; cyclin dependent kinase inhibitor 2A | CCND1; cyclin D1 | CCND2; cyclin D2 | CCND3; cyclin D3 | CDK4; cyclin dependent kinase 4 | CDK6; cyclin dependent kinase 6 | RB1; RB transcriptional corepre... | pancreatic ductal adenocarcinoma | Step 1: The variant is an A>T substitution at position 21970989 on chromosome 9, occurring in the CDKN2A gene.
Step 2: CDKN2A encodes multiple tumor suppressor proteins through alternative reading frames, most notably p16INK4a and p14ARF.
Step 3: The p16INK4a protein functions as a cyclin-dependent kinase inhibitor tha... | CCGTAGCTTGCATTAGATTCTCCGACCACTCTTTAGCTTCTCCTCCTATTCACACTTCATATTTACCCATTGCATTGGTTTTATAAACTCGCTCTCTGAAAATAGATTGTTATCTTCCTTAACGTCTGTTTCCCAGGTCGGGCAAGATAGCTTGGGACTGTAATCCCAGTACTTTAGGAGGAGGAGGGGGGATGATCGCTTGAGCCCAGATAACATGGTGAGACCTTCGTCTCTATTAAACAAACAAACAAACCCAGGCGTCGTGGCGTGCACCTGTGGTCCCAGCTAGTCGGGAGGCTCAGGTGGGAGAACCCCTTGAG... | CCGTAGCTTGCATTAGATTCTCCGACCACTCTTTAGCTTCTCCTCCTATTCACACTTCATATTTACCCATTGCATTGGTTTTATAAACTCGCTCTCTGAAAATAGATTGTTATCTTCCTTAACGTCTGTTTCCCAGGTCGGGCAAGATAGCTTGGGACTGTAATCCCAGTACTTTAGGAGGAGGAGGGGGGATGATCGCTTGAGCCCAGATAACATGGTGAGACCTTCGTCTCTATTAAACAAACAAACAAACCCAGGCGTCGTGGCGTGCACCTGTGGTCCCAGCTAGTCGGGAGGCTCAGGTGGGAGAACCCCTTGAG... |
End of preview. Expand in Data Studio
KEGG Biological Reasoning Dataset
1,449 entries from KEGG pathway database with variants from ClinVar/dbSNP/OMIM/COSMIC, featuring reasoning traces for mechanistic variant-to-disease prediction across 37 unique diseases.
Usage
from datasets import load_dataset
dataset = load_dataset("weicaijaden/kegg_reason")
example = dataset["train"][0]
print(example)
- Downloads last month
- 30